about
Neurotropic virus infections as the cause of immediate and delayed neuropathologyLocal CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal gangliaT-Cell tropism of simian varicella virus during primary infectionHSV neutralization by the microbicidal candidate C5ALongitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIVThe impact of impurities in synthetic peptides on the outcome of T-cell stimulation assays.High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa.Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitisDetection of Circovirus in Foxes with Meningoencephalitis, United Kingdom, 2009-2013.No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.Human herpes simplex virus keratitis: the pathogenesis revisited.Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.Central nervous system disease and genital disease in harbor porpoises (Phocoena phocoena) are associated with different herpesvirusesCharacterization of the immune response in ganglia after primary simian varicella virus infection.Clinical and corneal microbial profile of infectious keratitis in a high HIV prevalence setting in rural South Africa.Ocular infections in sub-Saharan Africa in the context of high HIV prevalence.Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients.HIV-infected individuals on long-term antiretroviral therapy are at higher risk for ocular disease.European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment.Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.Uveitis is predominantly of infectious origin in a high HIV and TB prevalence setting in rural South Africa.Simian varicella virus inhibits the interferon gamma signalling pathway.Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.Satellite glial cells in human trigeminal ganglia have a broad expression of functional Toll-like receptors.Early- and late-stage ocular complications of herpes zoster ophthalmicus in rural South Africa.Characterization of the varicella zoster virus (VZV)-specific intra-ocular T-cell response in patients with VZV-induced uveitis.Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G proteinIL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts.Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.Induction of the phoE promoter upon invasion of Salmonella typhimurium into eukaryotic cells.Good visual outcome of tuberculous chorioretinitis after ART initiation in a HIV-infected patient.Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infections.CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands.Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.Chlamydia trachomatis Biovar L2 Infection in Women in South Africa.In vitro and in vivo replication of seal gammaherpesviruses in cells of multiple species.
P50
Q24701724-55D76358-632C-4502-A3F7-BD25CDB3E064Q27333997-71A698CD-BF5C-42AD-A5B9-58765F8EE7D1Q27334810-D7C36C92-EB6C-4324-BC9C-5C1B161C195FQ28478074-0B82E626-99CB-4219-8295-40F0965D6408Q28660303-3A1570C9-22A4-48B4-8FFB-53F2CC1C320FQ33277057-F098C9F9-AD1B-4C7B-88CC-056DCE32A0A5Q33734155-8BFFB3B2-6495-4A06-B72F-669746AE3D33Q34354018-88F3F4A1-7B34-4E41-AF4A-6165A435CFE9Q35780323-276C4090-15AF-4BA7-BC60-91FE3FEA54EAQ35880899-2D2B4D36-AAAE-45D9-8C48-1E1D4C963C3FQ35994997-5B073817-269D-40B6-96BA-DCF04435D862Q36015799-001A32D4-E4C9-49D7-A5A3-D7903431B47BQ36380849-34CDED20-8E3D-4985-8A35-EC478CE23499Q36565958-56942875-C228-42BC-A011-F5AD5615C6FAQ36985292-E444C193-CB6A-4334-BCA0-3A4972A8709BQ37171150-B922774F-4AAC-47B6-9A89-6EED1CFB96E1Q38231302-58C9E211-1750-469F-A33A-C948B6D6F296Q38720773-E953AF30-F093-47EB-8E71-EE0A1B6CF538Q38776423-E4407690-B80B-4048-8350-86EC73E8D066Q38942259-EBE3C06F-C606-4195-B449-EA9793A6B3FFQ39016158-F611C8F9-BD98-48BC-BD56-96DA3149F4CAQ39164235-D6998F7D-3FFE-4496-A350-E723EDFC44F9Q39680333-7D0E8C77-7597-49B0-A1D0-9896FA035330Q40043931-FC743C81-F0F9-4B1B-90B9-8C38DDD04751Q40188312-DB98F737-63B5-4EA8-AD84-D97D1682130FQ40211022-0814A00A-3EE0-4568-A7AB-CBACC85E223AQ40215245-997C9FA3-CB5F-4214-98E4-DB523A5923BDQ40306282-FC806B0F-F0EB-43BA-AB9C-71E3AE233E18Q40594998-04853B99-E8BC-43A5-939E-075DC833AD2EQ40691425-C18BCD8F-BC8E-473B-AC99-F6722DE53333Q40871058-210EED2E-38FF-40A9-980D-EE4D406022B7Q40934895-2885E237-BA7F-4FB0-8D3B-0DC06E233BC7Q41285468-763F4EB5-0E05-4B27-9ABE-525F37767C8BQ41737073-78D3DECB-FDEA-451F-9248-94D29210FD56Q41922779-3050F3D7-0449-4134-A2AC-C5C914A3B233Q42149041-B6EEFF6D-E139-4F8C-8583-BAC96692BE4CQ42228862-9C4628D4-955E-4E0B-A7C6-5DFC8F9E9B20Q42280324-52E97872-B077-4E9E-9E09-88F006753B0EQ42650244-983C81E4-51DD-4BBE-9774-B7AE6B1BB5E1Q43221959-B5ADC602-32E0-4626-9469-8735FF71E4B7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Georges M Verjans
@nl
Georges M Verjans
@sl
Georges M. Verjans
@en
Georges M. Verjans
@es
type
label
Georges M Verjans
@nl
Georges M Verjans
@sl
Georges M. Verjans
@en
Georges M. Verjans
@es
prefLabel
Georges M Verjans
@nl
Georges M Verjans
@sl
Georges M. Verjans
@en
Georges M. Verjans
@es
P108
P106
P1153
7004542995
P31
P496
0000-0002-2465-2674